2 ML lebrikizumab-lbkz 125 MG/ML Pen Injector

RxNorm concept 2693903, clinical drug (scd). Prescribable name: lebrikizumab-lbkz 250 MG in 2 ML Pen Injector.

RxCUI: 2693903
Term type: Clinical drug (SCD)
Status: Active

Request

curl https://api.healthcare.dev/v1/drugs/rxnorm/2693903 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Concept

Ingredients and related concepts

Ingredients

lebrikizumab 2693758

Other names

lebrikizumab-lbkz 250 MG per 2 ML Pen Injector

Related concepts

lebrikizumab-lbkz 125 MG/ML (SCDC, consists of)
Pen Injector (DF, has dose form)
2 ML lebrikizumab-lbkz 125 MG/ML Pen Injector [Ebglyss] (SBD, has tradename)

Linked data

NDCs

RxNorm links no NDCs to this concept.

Use it

Look up 2693903 from code or an agent

curl

curl https://api.healthcare.dev/v1/drugs/rxnorm/2693903 \
  -H "Authorization: Bearer $HDEV_API_KEY"

MCP prompt

Using the healthcare.dev MCP server, look up RxNorm concept 2693903. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.

Get a free key RxNorm docs Connect the MCP server

Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.